12.09.2021, 1563 Zeichen
Marinomed: Marinomed Biotech AG, an Austrian science-based biotech company with globally marketed therapeutics derived from innovative proprietary technology platforms, announced that positive clinical data on the antiviral efficacy of Carragelose-containing lozenges have been published in the peer-reviewed journal International Journal of General Medicine. The clinical study investigated whether sucking of one Carragelose-containing (10 mg) lozenge would lead to sufficient iota-carrageenan concentrations in the saliva of 31 healthy subjects to neutralize seven human respiratory viruses that cause common colds as well as COVID-19. “These results further confirm what we have seen in several recent studies, both conducted by us and independently: Carragelose is an effective tool against respiratory viruses, including SARS-CoV-2. We are glad that with the data published here we were able to confirm that Carragelose lozenges release multiple times more active compound than necessary to neutralize all tested viruses,” said Dr. Eva Prieschl-Grassauer, Chief Scientific Officer at Marinomed. “It has become increasingly clear that the current pandemic will not end abruptly, but rather is SARS-CoV-2 here to stay. In light of the emerging variants of concern it will be important to have multiple lines of defence against COVID-19. Carragelose has the potential to act as an additional measure alongside vaccines to help contain the pandemic and to protect people.”
(From the 21st Austria weekly https://www.boerse-social.com/21staustria (09/09/2021)
kapitalmarkt-stimme.at daily voice 5/365: Wie kann man Karl Nehammer zu einem Aktionär machen? (Reprise)
Aktien auf dem Radar:Warimpex, Kapsch TrafficCom, Amag, Frequentis, Austriacard Holdings AG, Rosenbauer, EVN, FACC, OMV, SBO, AT&S, Telekom Austria, Athos Immobilien, Cleen Energy, Gurktaler AG VZ, Josef Manner & Comp. AG, Marinomed Biotech, Wolford, Polytec Group, Semperit, Porr, Zumtobel, RHI Magnesita, EuroTeleSites AG, Flughafen Wien, Kostad, Oberbank AG Stamm, BKS Bank Stamm, Pierer Mobility, UBM, Strabag.
Rosenbauer
Rosenbauer ist weltweit der führende Hersteller für Feuerwehrtechnik im abwehrenden Brand- und Katastrophenschutz. Als Vollsortimenter bietet Rosenbauer der Feuerwehr kommunale Löschfahrzeuge, Drehleitern, Hubrettungsbühnen, Flughafenfahrzeuge, Industriefahrzeuge, Sonderfahrzeuge, Löschsysteme, Feuerwehrausrüstung, stationäre Löschanlagen und im Bereich Telematik Lösungen für Fahrzeugmanagement und Einsatzmanagement.
>> Besuchen Sie 68 weitere Partner auf boerse-social.com/partner
Die Useletter "Morning Xpresso" und "Evening Xtrakt" heben sich deutlich von den gängigen Newslettern ab.
Beispiele ansehen bzw. kostenfrei anmelden. Wichtige Börse-Infos garantiert.
Newsletter abonnieren
Infos über neue Financial Literacy Audio Files für die Runplugged App
(kostenfrei downloaden über http://runplugged.com/spreadit)
per Newsletter erhalten